No association between exposure to perfluorinated compounds and congenital cryptorchidism: A nested case-control study Among 215 Boys from Denmark and Finland

Reproduction

Volumn 147, Issue 4, 2014, Pages 411-417

  Jensen, Dorte Vesterholm ^a   Christensen, Jeppe ^b   Virtanen, Helena E ^c   Skakkebæk, Niels E ^b   Main, Katharina M ^b   Toppari, Jorma ^c   Veje, Christine W ^b   Andersson, Anna Maria ^b   Nielsen, Flemming ^a   Grandjean, Philippe ^a   Jensen, Tina Kold ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; ALKANESULFONIC ACID; ENDOCRINE DISRUPTOR; FLUOROCARBON; OCTANOIC ACID DERIVATIVE;

COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CRYPTORCHISM; DENMARK; ENVIRONMENTAL EXPOSURE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; UMBILICAL CORD BLOOD; ADULT; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED; CHEMISTRY; CRYPTORCHIDISM; EPIDEMIOLOGY; FEMALE; FETUS BLOOD; PREGNANCY; PRENATAL EXPOSURE;

ADULT; ALKANESULFONIC ACIDS; CAPRYLATES; CASE-CONTROL STUDIES; CRYPTORCHIDISM; DENMARK; ENDOCRINE DISRUPTORS; FEMALE; FETAL BLOOD; FINLAND; FLUOROCARBONS; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84896364226     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-13-0444     Document Type: Conference Paper

References (29)

1. Austin ME, Kasturi BS, Barber M, Kannan K, Mohan Kumar PS & Mohan Kumar SM 2003 Neuroendocrine effects of perfluorooctane sulfonate in rats. Environmental Health Perspectives 111 1485-1489. (doi:10.1289/ehp. 6128) (Pubitemid 37120827)
2. Bay K, Main KM, Toppari J & Skakkebaek NE 2011 Testicular descent: Insl3, testosterone, genes and the intrauterine milieu. Nature Reviews. Urology 8 187-196. (doi:10.1038/nrurol.2011.23)
3. Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, Chellakooty M, Damgaard IN, Mau C, Reunanen M et al. 2004 Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363 1264-1269. (doi:10.1016/S0140-6736 (04) 15998-9) (Pubitemid 38496487)
4. Ehresman DJ, Froehlich JW, Olsen GW, Chang SC & Butenhoff JL 2007 Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environmental Research 103 176-184. (doi:10.1016/j. envres.2006.06.008) (Pubitemid 46123314)
5. Fei C, McLaughlin JK, Tarone RE & Olsen J 2007 Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environmental Health Perspectives 115 1677-1682. (doi:10.1289/ehp. 10506)
6. Fei C, McLaughlin JK, Lipworth L & Olsen J 2009 Maternal levels of perfluorinated chemicals and subfecundity. Human Reproduction 24 1200-1205. (doi:10.1093/humrep/den490)
7. Glynn A, Berger U, Bignert A, Ullah S, Aune M, Lignell S & Darnerud PO 2010 Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 1996-2010. Environmental Science & Technology 46 9071-9079. (doi:10.1021/es301168c)
8. Gutzkow KB, Haug LS, Thomsen C, Sabaredzovic A, Becher G & Brunborg G 2012 Placental transfer of perfluorinated compounds is selective - a Norwegian mother and child sub-cohort study. International Journal of Hygiene and Environmental Health 215 216-219. (doi:10. 1016/j.ijheh.2011.08.011)
9. Haug LS, Thomsen C & Becher G 2009 A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring. Journal of Chromatography. A 1216 385-393. (doi:10.1016/j.chroma.2008.10.113)
10. Jensen AA & Leffers H 2008 Emerging endocrine disrupters: perfluoroalkylated substances. International Journal of Andrology 31 161-169. (doi:10.1111/j.1365-2605.2008.00870.x)
11. Joensen UN, Veyrand B, Antignac JP, Blomberg Jensen M, Petersen JH, Marchand P, Skakkebæk NE, Andersson AM, Le Bizec B & Jørgensen N 2013 PFOS (perfluorooctanesulfonate) in serum is negatively associated with testosterone levels, but not with semen quality, in healthy men. Human Reproduction 28 599-608. (doi:10.1093/humrep/des425)
12. Krysiak-Baltyn K, Toppari J, Skakkebaek NE, Jensen TS, Virtanen HE, Schramm KW, Shen H, Vartiainen T, Kiviranta H, Taboureau O et al. 2010 Country-specific chemical signatures of persistent environmental compounds in breast milk. International Journal of Andrology 33 270-278. (doi:10.1111/j.1365- 2605.2009.00996.x)
13. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A & Seed J 2007 Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicological Sciences 99 366-394. (doi:10.1093/toxsci/kfm128) (Pubitemid 351753056)
14. Lindstrom AB, Strynar MJ & Libelo EL 2011 Polyfluorinated compounds: past, present, and future. Environmental Science & Technology 45 7954-7961. (doi:10.1021/es2011622)
15. Monroy R, Morrison K, Teo K, Atkinson S, Kubwabo C, Stewart B & Foster WG 2008 Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environmental Research 108 56-62. (doi:10.1016/j.envres.2008.06.001)
16. Nelson JW, Scammell MK, Hatch EE & Webster TF 2006 Social disparities in exposures to bisphenol A and polyfluoroalkyl chemicals: a crosssectional study within NHANES 2003-2006. Environmental Health 11 10. (doi:10.1186/1476- 069X-11-10)
17. Olsen GW, Butenhoff JL & Zobel LR 2009 Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reproductive Toxicology 27 212-230. (doi:10.1016/j.reprotox.2009. 02.001)
18. Rantakokko P, Main KM, Wohlfart-Veje C, Kiviranta H, Airaksinen R, Vartiainen T, Skakkebæk NE, Toppari J & Virtanen HE 2013 Association of placenta organotin concentrations with congenital cryptorchidism and reproductive hormone levels in 280 newborn boys from Denmark and Finland. Human Reproduction 28 1647-1660. (doi:10.1093/humrep/det040)
19. Savitz DA, Stein CR, Bartell SM, Elston B, Gong J, Shin HM & Wellenius GA 2012 Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology 23 386-392. (doi:10.1097/EDE. 0b013e31824cb93b)
20. Scorer CG 1964 The descent of the testis. Archives of Disease in Childhood 39 605-609. (doi:10.1136/adc.39.208.605)
21. Shen H, Main KM, Andersson AM, Damgaard IN, Virtanen HE, Skakkebaek NE, Toppari J & Schramm KW 2008 Concentrations of persistent organochlorine compounds in human milk and placenta are higher in Denmark than in Finland. Human Reproduction 23 201-210. (Pubitemid 351767306)
22. Skakkebaek NE, Rajpert-De Meyts E & Main KM 2001 Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction 16 972-978. (doi:10. 1093/humrep/16.5.972) (Pubitemid 32451837)
23. Skakkebaek NE, Jørgensen N, Main KM, Rajpert-De Meyts E, Leffers H, Andersson AM, Juul A, Carlsen E, Mortensen GK, Jensen TK et al. 2006 Is human fecundity declining? International Journal of Andrology 29 2-11. (doi:10.1111/j.1365-2605.2005.00573.x)
24. Stein CR, Savitz DA & Dougan M 2009 Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. American Journal of Epidemiology 170 837-846. (doi:10.1093/aje/kwp212)
25. Vestergaard S, Nielsen F, Andersson AM, Hjøllund NH, Grandjean P, Andersen HR & Jensen TK 2012 Association between perfluorinated compounds and time to pregnancy in a prospective cohort of Danish couples attempting to conceive. Human Reproduction 27 873-880. (doi:10.1093/humrep/der450)
26. Washino N, Saijo Y, Sasaki S, Kato S, Ban S, Konishi K, Ito R, Nakata A, Iwasaki Y, Saito K et al. 2009 Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environmental Health Perspectives 117 660-667. (doi:10.1289/ehp. 11681)
27. Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB & Sharpe RM 2008 Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. Journal of Clinical Investigation 118 1479-1490. (doi:10.1172/JCI34241) (Pubitemid 351500441)
28. White SS, Calafat AM, Kuklenyik Z, Villanueva L, Zehr RD, Helfant L, Strynar MJ, Lindstrom AB, Thibodeaux JR, Wood C et al. 2007 Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicological Sciences 96 133-144. (doi:10.1093/toxsci/ kfl177) (Pubitemid 46323216)
29. Ye L, Su ZJ & Ge RS 2011 Inhibitors of testosterone biosynthetic and metabolic activation enzymes. Molecules 16 9983-10001. (doi:10. 3390/molecules16129983)